Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.
Status:
Terminated
Trial end date:
2020-04-03
Target enrollment:
Participant gender:
Summary
The study is intended to assess the relative bioavailability of 2 different abediterol
nebulised formulations (test) and the dry powder formulation (reference). The study results
will provide information on the pharmacokinetic (PK) profile following use of the 3 devices
to be used in further clinical development.